Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Targeting LTC Facility Overprescribing, Citing Antipsychotics

Executive Summary

The Centers for Medicare and Medicaid Services is proposing a new Medicare requirement that consulting pharmacists serving long-term care facilities maintain independence from the facility to help avoid drug “overprescribing and overutilization.”

You may also be interested in...



CMS Initiative To Lower Antipsychotic Drug Use In Nursing Homes Showing Success

A program launched in 2012, the National Partnership to Improve Dementia Care, is on its way to meeting goals of lowering the use of antipsychotic drugs in nursing homes by 15%, with 11 states already hitting that target.

Nursing Home Overprescribing: CMS Urges Voluntary Remedies, Withholds Regulation

CMS will not implement an earlier regulatory proposal requiring that consultant pharmacists maintain independence from long-term care facilities or drug firms at this point.

Nursing Home Overprescribing: Pharmacist Independence Requirement Should Start As Demo, APhA Says

CMS’ proposal to reduce overprescribing in nursing homes draws cautiously favorable response from national pharmacist group, but long-term care pharmacy firm Omnicare argues the agency has not provided adequate justification for its plan.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS053832

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel